Trial Profile
An International, Double-Blind, Randomized, Multi-Center, Parallel Group, Historical-Control Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (greater than or equal to 16 to 75 Years Old) With Partial Onset Seizures With or Without Secondary Generalization.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary)
- Indications Partial epilepsies; Seizures
- Focus Registrational; Therapeutic Use
- Sponsors UCB
- 09 Apr 2022 This trial has been completed in Spain (End Date: 9 March 2010) according to European Clinical Trials Database record
- 01 Apr 2022 This trial has been completed in France (End Date: 9 March 2010) according to European Clinical Trials Database record.
- 28 Apr 2012 Planned number of patients changed from 178 to 223 as reported by European Clinical Trials Database.